AJA Asian Journal of Anesthesiology

Advancing, Capability, Improving lives

Review Article
Volume 49, Issue 3, Pages 105-108
Ming-Cheng Chang 1.2 , Shou-Zen Fan 1 , Po-Ni Hsiao 1 , Wen-Fang Cheng 2.3.4 , Wei-Zen Sun 1
2360 Views


Abstract

Morphine is a widely used drug for analgesia and substance abuse. It has been accepted as a safe medication with great analgesic efficacy. Previous studies have reported that morphine is highly associated with the risk of immunosuppressive effects. Although the observed clinical effects suggest that morphine has the immunomodulatory capabilities, the mechanism of its action is still unclear. Here we review morphine on the bench to improve our understanding of the drug on the host immunity at the bedside. Studies of the effects of morphine on the innate and adaptive immune systems as well as immune responses are also discussed.

Keywords

adaptive immunity; analgesia; innate immunity; morphine;


1. Introduction

Morphine can be used for analgesia. Opiate drugs are widely prescribed drugs for pain management clinically. Despite its clinical efficacy for pain control, the common side effects of opiate drugs include nausea and vomiting123 due to a central action of morphine stimulating the part of the brain concerned with vomiting called the chemoreceptor trigger zone.4 The side effects of morphine on the other parts of the central nervous system are dependence leading to addiction,5 cough suppression,67 and sedation.89 Morphine can also induce histamine release, which causes itching of the skin and nose, and a mild flushing of the skin.110 Nonetheless, as investigations of morphine continue, evidences suggest that morphine is highly associated with the risk of immunosuppression as revealed by both in vitro and in vivo studies.11121314 Important investigations and studies are being pursued on the immunomodulatory effects of morphine on host immunity. Sabita et al15 reported that chronic morphine treatment in vivo could increase the Th2 differentiation of CD4+ T cells. In contrast to the activation of CD4+ helper T lymphocytes, the activity of CD8+ cytotoxic T lymphocytes was suppressed in the cellular immune response, when acute morphine was administered.16 Despite morphine has been studied on the immune responses in a lot of investigations, the mechanisms of how morphine influences the host immunity is still unclear. We will focus our attention on the effects of morphine on immunocytes to understand the possible mechanisms of this drug when being used clinically in patients with a wide variety of diseases.

2. Actions of morphine on the immune system

The immune mechanisms that occur in response to pathogens can be divided into the early immune response known as innate immunity. And the late immune response, which is specific is well-known as adaptive immunity. Studies have suggested that morphine has effects on both innate and adaptive immunities.

2.1. Innate immunity

The innate immunity is the immune system, which is the first line defense against infection. It includes a variety of cytokines and cells and mechanisms that defend the host from invasion of the body with organisms in a non-specific manner. Innate immunity can protect the host against a broad range of infections. In the mucosa of gastrointestinal tract, the innate immune system contributes to health and diseases through monitoring the enteric microbiota. Key participants in intestinal innate immune defenses are macrophages. Frenklakh et al17 first reported that macrophages isolated from mice receiving morphine demonstrated a greater apoptosis status than that of the control mice. The increasing macrophage injury by morphine can correlate with the degradation of the host defense barrier.17 Beside, morphine also affects the expression of innate immunity-related cytokines. Morphine can inhibit the secretion of various cytokines, which belong to the humoral component of innate immunity, including IL-1β, IL-2, and tumor necrosis factor alpha (TNF-α).

2.2. Regulation of phagocytosis

Phagocytosis is the process in which the cells swallow large particles, for example, as a pathogen crosses the epithelial barrier to enter host tissue. These foreign particles (pathogen) usually encounter host macrophages or neutrophils, which can recognize phagosize and then destroy the pathogens. However, studies showed that morphine could inhibit the phagocytotic activity of neutrophils18 and monocytes.19 Shirzad et al20 demonstrated a significantly decreased phagocytotic activity in animal with long-term morphine treatment. Tomassini et al21 further identified that opioid receptors μ and δ are essential for morphine-mediated inhibition of phagocytosis of peritoneal macrophages. Human monocytes treated with morphine also showed suppression of their phagocytotic activity.22 The mechanism by which morphine inhibited macrophage phagocytosis could be mediated by enhancing cyclic adenosine monophosphate expression.23 Besides, morphine can also stimulate the release of nitric oxide, which suppresses phagocytotic activity.18 There are several mechanisms such as NF-κB24 and P38 MAP kinase24 that might be involved in morphine-mediated phagocytotic inhibition.

2.3. Soluble immune mediators

A key mechanism to regulate innate immune system is to produce cytokines by immunocytes. Cytokines such as IL-1, IL-2, IL-6, and TNF-α play important roles in the pathogenesis of many immune-mediated diseases. Production of IL-2 by immunocytes is most important because it induces a variety of well-defined subsequent immune responses. Previous study also suggested that suppression of immune function by morphine could contribute to the disruption of cytokine expression including IL-2.25 The mechanism to suppress IL-2 expression in activated human T lymphocytes was that morphine could inhibit the activation of transcription factors AP-1, NFAT, and NF-κB,426 which is essential for IL-2 trans-activation. In clinical studies, morphine-treated peripheral blood mononuclear cells also decreased the secretion of IL-2 and IFN-γ.23 These studies suggested that morphine can influence cytokine-mediated immune responses by the downregulation of IL-2.

The role of morphine in the influence on TNF-α has been investigated in numerous animal models and patients as well. Morphine can also reduce the production of TNF-α by mask cells27 and consequently decreases early peritoneal innate immunity responses.27 Chronic morphine treatment can decrease IL-1 and IL-6 expression.28 In infectious state, the lack of TNF-α, IL-1, and IL-6 expression will delay the recruitment of neutrophils, which increases the susceptibility for bacteria infection.28 One mechanism by which morphine inhibits the production of TNF-α is the suppression of extracellular signal-regulated kinase pathway.29 The inhibition of extracellular signal-regulated kinase pathway not only suppresses the host immunity but also enhances the tolerance in morphine treatment.29 Oppositely, morphine treatment has been reported to stimulate TNF-α secretion in HIV-associated nephropathic development.30 The increase of TNF-α will further stimulate nitric oxide generation, which promotes macrophage apoptosis.30 Taken together, morphine could act as an immunosuppressor in cytokine-mediated immunity.

2.4. Natural killer cells

The role of the innate immune system in regulating tumorigenesis is not only limited to soluble mediators but also includes immunocytes. Aside from macrophages, natural killer (NK) cells can also kill intracellular pathogens and tumor cells. Morphine suppresses NK cell activity has also been investigated in the animal model. The function of NK cells significantly decreased when treated the mice with morphine. However, the opiate antagonists naloxone and naltrexone could completely block the effect of morphine on NK cells and could also restore the function of NK cells.31 Morphine could inhibit NK cell-mediated cytolytic effects against breast cancer cells in rat model.3233 Clinical observation also demonstrated that the activity of NK cell decreased in surgical patients receiving morphine 24 h postoperatively.34 These studies indicated that morphine plays an important role in tumorigenesis by means of inhibiting the activity of NK cells.

2.5. Cell migration

The migration of leukocytes mediated by chemokine IL-8 is important for innate immunity because immunocytes can contact the foreign pathogens.3536 In the tumor microenvironment, neutrophils migrate to the site of invasion by means of chemotaxis, and this process is regulated by chemokine gradients including IL-8.31 The chemotaxis of neutrophils triggered by IL-8 has been reported to be suppressed by morphine.37 Morphine can inhibit the chemoattractant protein, CXCR-1, which is upregulated by IL-8. Lesser CXCR-1 expression in neutrophils after morphine treatment was also observed.38

Adhesion of leukocytes to the endothelium is another important issue for immunocytes migration and immunity.17 It requires the involvement of integrins family. Molecules including LFA-139 and Mac-13 of leukocytes may bind to the immunoglobulin-family adhesion proteins such as intercellular adhesion molecule-1 (ICAM-1) and ICAM-2 on endothelium. Inflammatory stimuli, TNF-α, and IL-1 can induce the expression of ICAM-1. In vitro studies show that morphine can decrease both the expression of ICAM-1 and the adhesion of neutrophils.40 Morphine could further generate anti-inflammatory effects by reducing the adhesion of leukocytes to the extracellular matrix proteins. Evidences revealed integrins and chemokines can be involved in the compromising immunity.4142 TNF-α and monocyte chemoattractant protein-1 are two mediators of inflammation because they can stimulate leukocyte adhesion to extracellular matrix proteins.43 In addition to TNF-α, morphine can result in a significant inhibition of lipopolysaccharide-induced synthesis of monocyte chemoattractant protein-1.44 Miyagi et al45 revealed that morphine could interrupt chemokine-mediated immune functions in pathogen-mediated immunocytes migration. Overall, morphine can enhance cell adhesion-molecule–mediated adhesion in neutrophils to disrupt the host immunity. It seems that chemokines and opioids can interact and regulate host immunity. However, the detailed mechanism of morphine suppressing the host immunity by means of leukocyte migration needs further investigations.

3. Adaptive immunity

3.1. B cells

B lymphocytes play an important role in upregulating immune protein including the major histocompatibility complex class II (MHC II) molecules.46 The effects of morphine on B lymphocytes-mediated immunity and antibody production have mostly been studied in animal models. Morphine resulted in the reduction of B cells and macrophages in both spleen and peritoneal cavity.47 Subcutaneous injection of morphine can reduce the proliferative activity and the function of B cells in both the spleen and lymph nodes.4849 In vivo study also revealed that morphine could reduce the MHC II expression on the leukocytes, especially the B lymphocytes.50 Nugent et al51 also reported that morphine could also inhibit IL-4 upregulated MHC II gene expression. Besides, morphine could significantly inhibit the production of antigen-specific IgA and IgG. However, these phenomena could be rescued by the antagonist of opioid receptor, naltrexone.52 The studies indicated that morphine has a downregulatory effect on B cell-mediated immunity and antibody production. The possible mechanism can be the disruption of the expression of MHC II molecule and reduction of IL-4 secretion. And then these processes can inhibit the host immunity and increase the susceptibility to pathogenic infections.

3.2. T cells

T cells are divided into two broad classes depending on the expression of molecule on the cell surface: CD4 and CD8. The CD4+ T cells are known as T helper cells to act in assisting other white blood cells during the immunologic processes. The CD8+ T cells are known as cytotoxic T cells, which act on destroying virally infected or tumor cells. Morphine has been found to alter CD4+ and CD8+ subpopulations of T cells.1314 Both healthy individuals26 and patients receiving postoperative pain control53 when taking morphine, showed a decrease in the population of CD4+ T cells in their peripheral blood. Studies also showed that morphine can inhibit the proliferation of T cells in in vitro experiments.1454 One important mechanism to suppress the proliferation of T cells is to block T-cell receptor (TCR) signaling as well as co-receptor CD28 and/or co-stimulatory molecules (such as CD80 and CD86) on the activated antigen presenting cells. Studies have revealed that morphine could suppress T-cell-mediated immunity by means of inhibiting TCR signaling.4855 Besides, morphine could not only suppress the activation of TCR downstream signaling cascades MAPK, LAT, and Zap70 but also inhibit the phosphorylation of TCR initiating signaling molecule, Lck.55

The suppression of host immunity by inhibiting T-cell responses may be a mechanism of morphine-induced immunocompromise. While activation, naive CD4 T cells could differentiate into either T helper 1 (Th1) or T helper 2 (Th2) cells.56 Th1 cells are associated with superior cell-mediated and cytotoxic cell responses by secreting IFN-γ, whereas Th2 cells are associated with humoral immunity by secreting IL-4, IL-5, IL-6, IL-10, and IL-13.56 These cytokines can further stimulate and activate T cells. In the Th1-mediated immunity, morphine was found to decrease IFN-γ levels in anti-CD3/CD28-stimulated T cells57 or in DNA vaccination in in vivo experiments.13 In addition to IFN-γ-mediated Th1 immunity, IL-12 is another important cytokine that could regulate antigen-specific T-cell immunological response. Morphine combining with HIV-1 transactivating protein, Tat, has been demonstrated to induce the mRNA expression of inducible nitric oxide synthase27, CD40 ligand, IFN-γ-inducible protein 10, and the proinflammatory cytokines TNF-α and IL-1β.58 These observations can explain why morphine abusers with HIV infection have a global immune-compromised status.

IL-10 has also been reported to suppress Th1 cells maturation and activation in the development of Th1 cells.59 Sacerdote et al60 observed that mice receiving long-term morphine could significantly increase the production of IL-10 in the splenocytes. Besides, morphine can increase production of IL-461 and IL-562 and decrease IFN-γ production in HIV-1 infection patients’ peripheral blood mononuclear cells.44 Overall, these observations support the hypothesis that morphine can modulate Th1-mediated adaptive immunity, when in the situations of addiction or long-term use.

4. Conclusion

Morphine is a widely used drug for analgesia and substance abuse. It has been accepted as a safe medication with great analgesic efficacy. Previous studies reported that morphine is highly associated with the risk of immunomodulatory and immunosuppressive effects.11 The mechanisms underlying morphine-induced immunosuppression, although not well delineated, may include direct and indirect actions on the cellular immunity system.164549 To focus on the influence of morphine on host immunity, morphine can alter mitogen-stimulated T and B-cell responses, attenuate antibody production, reduce NK cell activity, and suppress the proliferation and functions of T and B lymphocytes. Indeed, the impact of morphine use or morphine tolerance on cellular immunity remains to be elucidated. So much the better, should we understand the mechanism of morphine and its effects on immunity we can then provide a better use of this anesthetic drug in the clinical use.


References

1
Y.C. Yeh, T.F. Lin, H.C. Chang, W.S. Chan, Y.P. Wang, C.J. Lin, et al.
Combination of low-dose nalbuphine and morphine in patient-controlled analgesia decreases incidence of opioid-related side effects
J Formos Med Assoc, 108 (7) (2009), pp. 548-553
2
Y.C. Yeh, T.F. Lin, F.S. Lin, Y.P. Wang, C.J. Lin, W.Z. Sun
Combination of opioid agonist and agonist-antagonist: patient-controlled analgesia requirement and adverse events among different-ratio morphine and nalbuphine admixtures for postoperative pain
Br J Anaesth, 101 (4) (2008), pp. 542-548
3
S.L. Guo, C.J. Lin, H.H. Huang, L.K. Chen, W.Z. Sun
Reversal of morphine with naloxone precipitates haloperidol-induced extrapyramidal side effects
J Pain Symptom Manage, 31 (5) (2006), pp. 391-392
4
K.P. Bhargava, K.S. Dixit, Y.K. Gupta
Enkephalin receptors in the emetic chemoreceptor trigger zone of the dog
Br J Pharmacol, 72 (3) (1981), pp. 471-475
5
F. Jardinaud, B.P. Roques, F. Noble
Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice
Behav Brain Res, 173 (2) (2006), pp. 255-261
6
H.A. Hutchings, R. Eccles
The opioid agonist codeine and antagonist naltrexone do not affect voluntary suppression of capsaicin induced cough in healthy subjects
Eur Respir J, 7 (4) (1994), pp. 715-719
7
T.F. Lin, Y.C. Yeh, F.S. Lin, Y.P. Wang, C.J. Lin, W.Z. Sun, et al.
Effect of combining dexmedetomidine and morphine for intravenous patient-controlled analgesia
Br J Anaesth, 102 (1) (2009), pp. 117-122
8
T.F. Lin, Y.C. Yeh, Y.H. Yen, Y.P. Wang, C.J. Lin, W.Z. Sun
Antiemetic and analgesic-sparing effects of diphenhydramine added to morphine intravenous patient-controlled analgesia
Br J Anaesth, 94 (6) (2005), pp. 835-839
9
Y.C. Yeh, T.F. Lin, C.H. Wang, Y.P. Wang, C.J. Lin, W.Z. Sun
Effect of combining ultralow-dose naloxone with morphine in intravenous patient-controlled analgesia: the cut-off ratio of naloxone to morphine for antiemesis after gynecologic surgery
J Formos Med Assoc, 107 (6) (2008), pp. 478-484
10
Y.C. Huang, S.K. Tsai, C.H. Huang, M.H. Wang, P.L. Lin, L.K. Chen, et al.
Intravenous tenoxicam reduces uterine cramps after Cesarean delivery
Can J Anaesth, 49 (4) (2002), pp. 384-387
11
P. Sacerdote, B. Manfredi, P. Mantegazza, A.E. Panerai
Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study
Br J Pharmacol, 121 (4) (1997), pp. 834-840
12
M.P. Yeager, T.A. Colacchio, C.T. Yu, L. Hildebrandt, A.L. Howell, J. Weiss, et al.
Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers
Anesthesiology, 83 (3) (1995), pp. 500-508
13
W.Z. Sun, M.C. Chang, P.N. Hsiao, C.A. Chen, Y.T. Hsu, C.Y. Hsieh, et al.
Morphine-sparing effect by COX-1 inhibitor sustains analgesic function without compromising antigen-specific immunity and antitumor effect of naked DNA vaccine
Int J Immunopathol Pharmacol, 23 (1) (2010), pp. 91-104
14
W.F. Cheng, L.K. Chen, C.A. Chen, M.C. Chang, P.N. Hsiao, Y.N. Su, et al.
Chimeric DNA vaccine reverses morphine-induced immunosuppression and tumorigenesis
Mol Ther, 13 (1) (2006), pp. 203-210
15
S. Roy, J. Wang, R. Charboneau, H.H. Loh, R.A. Barke
Morphine induces CD4+ T cell IL-4 expression through an adenylyl cyclase mechanism independent of the protein kinase A pathway
J Immunol, 175 (10) (2005), pp. 6361-6367
16
S. Mojadadi, A. Jamali, B. Khansarinejad, H. Soleimanjahi, T. Bamdad
Acute morphine administration reduces cell-mediated immunity and induces reactivation of latent herpes simplex virus type 1 in BALB/c mice
Cell Mol Immunol, 6 (2) (2009), pp. 111-116
Article   CrossRef  
17
L. Frenklakh, R.S. Bhat, M. Bhaskaran, S. Sharma, M. Sharma, A. Dinda, et al.
Morphine-induced degradation of the host defense barrier role of intestinal mucosal injury
Dig Dis Sci, 51 (2) (2006), pp. 318-325
18
I.D. Welters, A. Menzebach, Y. Goumon, T.W. Langefeld, H. Teschemacher, G. Hempelmann, et al.
Morphine suppresses complement receptor expression, phagocytosis, and respiratory burst in neutrophils by a nitric oxide and mu(3) opiate receptor-dependent mechanism
J Neuroimmunol, 111 (1–2) (2000), pp. 139-145
19
H. Bosshart
Morphine-mediated suppression of phagocytosis
Int Immunopharmacol, 10 (2) (2010), pp. 264-265
20
H. Shirzad, M. Shahrani, M. Rafieian-Kopaei
Comparison of morphine and tramadol effects on phagocytic activity of mice peritoneal phagocytes in vivo
Int Immunopharmacol, 9 (7–8) (2009), pp. 968-970
21
N. Tomassini, F.L. Renaud, S. Roy, H.H. Loh
Mu and delta receptors mediate morphine effects on phagocytosis by murine peritoneal macrophages
J Neuroimmunol, 136 (1–2) (2003), pp. 9-16
22
M. Delgado-Velez, A. Lugo-Chinchilla, L. Lizardo, I. Morales, Y. Robles, N. Bruno, et al.
Chronic exposure of human macrophages in vitro to morphine and methadone induces a putative tolerant/dependent state
J Neuroimmunol, 196 (1–2) (2008), pp. 94-100
23
A.M. Lugo-Chinchilla, D. Baez, M. Velez, C. Ildefonso, F.L. Renaud
Altered subcellular signaling in murine peritoneal macrophages upon chronic morphine exposure
J Neuroimmunol, 176 (1–2) (2006), pp. 86-94
24
M. Bhaskaran, A.A. Kapasi, K. Reddy, P.C. Singhal
Morphine priming rescues high-dose morphine-induced biological perturbations
J Infect Dis, 195 (12) (2007), pp. 1860-1869
25
T.K. Eisenstein, J.L. Bussiere, T.J. Rogers, M.W. Adler
Immunosuppressive effects of morphine on immune responses in mice
Adv Exp Med Biol., 335 (1993), pp. 41-52
26
A. Azarang, M. Mahmoodi, S. Rajabalian, M.A. Shekari, J. Nosratabadi, N. Rezaei
T-helper 1 and 2 serum cytokine assay in chronic opioid addicts
Eur Cytokine Netw, 18 (4) (2007), pp. 210-214
27
I.K. Madera-Salcedo, S.L. Cruz, C. Gonzalez-Espinosa
Morphine decreases early peritoneal innate immunity responses in Swiss-Webster and C57BL6/J mice through the inhibition of mast cell TNF-alpha release
J Neuroimmunol, 232 (1–2) (2011), pp. 101-107
28
J. Wang, R.A. Barke, R. Charboneau, S. Roy
Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection
J Immunol, 174 (1) (2005), pp. 426-434
29
M. Mir, Z. Wang, K. Tangella, G. Popescu
Diffraction phase cytometry: blood on a CD-ROM
Opt Express, 17 (4) (2009), pp. 2579-2585
30
Y. Choi, L.F. Chuang, K.M. Lam, H.F. Kung, J.M. Wang, B.I. Osburn, et al.
Inhibition of chemokine-induced chemotaxis of monkey leukocytes by mu-opioid receptor agonists
In Vivo, 13 (5) (1999), pp. 389-396
31
D.O. Freier, B.A. Fuchs
A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity
J Pharmacol Exp Ther, 270 (3) (1994), pp. 1127-1133
32
G.G. Page, S. Ben-Eliyahu, R. Yirmiya, J.C. Liebeskind
Morphine attenuates surgery-induced enhancement of metastatic colonization in rats
Pain, 54 (1) (1993), pp. 21-28
33
G.G. Page, W.P. Blakely, S. Ben-Eliyahu
Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats
Pain, 90 (1–2) (2001), pp. 191-199
34
T. Yokota, K. Uehara, Y. Nomoto
Addition of noradrenaline to intrathecal morphine augments the postoperative suppression of natural killer cell activity
J Anesth, 18 (3) (2004), pp. 190-195
35
D. Yang, O. Chertov, J.J. Oppenheim
Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37)
J Leukoc Biol, 69 (5) (2001), pp. 691-697
36
E.F. Morand, M. Leech
Macrophage migration inhibitory factor in rheumatoid arthritis
Front Biosci, 10 (2005), pp. 12-22
37
J.L. Dunne, R.G. Collins, A.L. Beaudet, C.M. Ballantyne, K. Ley
Mac-1, but not LFA-1, uses intercellular adhesion molecule-1 to mediate slow leukocyte rolling in TNF-alpha-induced inflammation
J Immunol, 171 (11) (2003), pp. 6105-6111
38
P. Yossuck, B.J. Nightengale, J.E. Fortney, L.F. Gibson
Effect of morphine sulfate on neonatal neutrophil chemotaxis
Clin J Pain, 24 (1) (2008), pp. 76-82
39
K.M. Greeneltch, A.E. Kelly-Welch, Y. Shi, A.D. Keegan
Chronic morphine treatment promotes specific Th2 cytokine production by murine T cells in vitro via a Fas/Fas ligand-dependent mechanism
J Immunol, 175 (8) (2005), pp. 4999-5005
40
T.J. Min, J.I. Kim, J.H. Kim, K.H. Noh, T.W. Kim, W.Y. Kim, et al.
Morphine postconditioning attenuates ICAM-1 expression on endothelial cells
J Korean Med Sci, 26 (2) (2011), pp. 290-296
Article   CrossRef  
41
M.A. Schneider, J.G. Meingassner, M. Lipp, H.D. Moore, A. Rot
CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells
J Exp Med, 204 (4) (2007), pp. 735-745
42
I.R. Williams
CCR6 and CCL20: partners in intestinal immunity and lymphorganogenesis
Ann N Y Acad Sci, 1072 (2006), pp. 52-61
43
B.S. Weeks, S. Goldman, S. Touma, M. Payne, P. Cadet, G.B. Stefano
Morphine inhibits indolactam V-induced U937 cell adhesion and gelatinase secretion
J Cell Physiol, 189 (2) (2001), pp. 179-188
44
J.W. Homan, A.D. Steele, C. Martinand-Mari, T.J. Rogers, E.E. Henderson, R. Charubala, et al.
Inhibition of morphine-potentiated HIV-1 replication in peripheral blood mononuclear cells with the nuclease-resistant 2-5A agonist analog, 2-5A(N6B)
J Acquir Immune Defic Syndr, 30 (1) (2002), pp. 9-20
45
T. Miyagi, L.F. Chuang, K.M. Lam, H. Kung, J.M. Wang, B.I. Osburn, et al.
Opioids suppress chemokine-mediated migration of monkey neutrophils and monocytes—an instant response
Immunopharmacology, 47 (1) (2000), pp. 53-62
46
M. Irla, N. Kupfer, T. Suter, R. Lissilaa, M. Benkhoucha, J. Skupsky, et al.
MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity
J Exp Med, 207 (9) (2010), pp. 1891-1905
47
M.E. Hilburger, M.W. Adler, T.J. Rogers, T.K. Eisenstein
Morphine alters macrophage and lymphocyte populations in the spleen and peritoneal cavity
J Neuroimmunol, 80 (1–2) (1997), pp. 106-114
48
D.T. Lysle, M.E. Coussons, V.J. Watts, E.H. Bennett, L.A. Dykstra
Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone
J Pharmacol Exp Ther, 265 (3) (1993), pp. 1071-1078
49
T. Nguyen, J. Kramer, R. Vallejo, G. Stanton, B.A. Heidenreich, R. Benyamin, et al.
Citalopram enhances B cell numbers in a murine model of morphine-induced immunosuppression
Pain Pract, 9 (3) (2009), pp. 195-205
50
K. Beagles, A. Wellstein, B. Bayer
Systemic morphine administration suppresses genes involved in antigen presentation
Mol Pharmacol, 65 (2) (2004), pp. 437-442
51
A.L. Nugent, R.A. Houghtling, B.M. Bayer
Morphine suppresses MHC-II expression on circulating B lymphocytes via activation of the HPA
J Neuroimmune Pharmacol, 6 (1) (2011), pp. 130-141
52
X. Peng, J.J. Cebra, M.W. Adler, J.J. Meissler Jr., A. Cowan, P. Feng, et al.
Morphine inhibits mucosal antibody responses and TGF-beta mRNA in gut-associated lymphoid tissue following oral cholera toxin in mice
J Immunol, 167 (7) (2001), pp. 3677-3681
53
W. Li, H.Z. Tang, Y.B. Jiang, M.X. Xu
[Influence of different doses of fentanyl on T-lymphocyte subpopulations and natural killer cells of patients with esophageal tumor during preoperation and postoperation]
Ai Zheng, 22 (6) (2003), pp. 634-636
54
J. Wang, R. Charboneau, S. Balasubramanian, R.A. Barke, H.H. Loh, S. Roy
Morphine modulates lymph node-derived T lymphocyte function: role of caspase-3, -8, and nitric oxide
J Leukoc Biol, 70 (4) (2001), pp. 527-536
55
C. Borner, B. Warnick, M. Smida, R. Hartig, J.A. Lindquist, B. Schraven, et al.
Mechanisms of opioid-mediated inhibition of human T cell receptor signaling
J Immunol, 183 (2) (2009), pp. 882-889
56
J. Zhu, H. Yamane, W.E. Paul
Differentiation of effector CD4 T cell populations (*)
Annu Rev Immunol, 28 (2010), pp. 445-489
57
J. Wang, R.A. Barke, R. Charboneau, H.H. Loh, S. Roy
Morphine negatively regulates interferon-gamma promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways
J Biol Chem, 278 (39) (2003), pp. 37622-37631
58
S.M. Bokhari, H. Yao, C. Bethel-Brown, P. Fuwang, R. Williams, N.K. Dhillon, et al.
Morphine enhances Tat-induced activation in murine microglia
J Neurovirol, 15 (3) (2009), pp. 219-228
59
A. O’Garra, K.M. Murphy
From IL-10 to IL-12: how pathogens and their products stimulate APCs to induce T(H)1 development
Nat Immunol, 10 (9) (2009), pp. 929-932
60
P. Sacerdote, E. Limiroli, L. Gaspani
Experimental evidence for immunomodulatory effects of opioids
Adv Exp Med Biol., 521 (2003), pp. 106-116
61
I.A. Casalinuovo, R. Gaziano, P. Di Francesco
Cytokine pattern secretion by murine spleen cells after inactivated Candida albicans immunization. Effect of cocaine and morphine treatment
Immunopharmacol Immunotoxicol, 22 (1) (2000), pp. 35-48
62
S. Roy, S. Balasubramanian, S. Sumandeep, R. Charboneau, J. Wang, D. Melnyk, et al.
Morphine directs T cells toward T(H2) differentiation
Surgery, 130 (2) (2001), pp. 304-309

References

Close